−£5,272
−1132%vs Nov 2023Active13735777Private limited companyPinner
JERICHO PHARMA LIMITED
Significant control: Mantix Consulting Limited (25–50%), Nias Holdings Limited (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Jericho Pharma Limited sell?
Registered activity: Dispensing chemist in specialised stores (SIC 47730). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
JERICHO PHARMA LIMITED is an active private limited company (company number 13735777) incorporated on 10 November 2021, registered in Pinner. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest small accounts cover the period ending 30 November 2024, showing net assets of −£5,272 and cash of £12k, with 2 employees on average. Net assets fell 1132% on the prior period (£511).
Peer position · net assets
By net assets it sits in the bottom quarter of 900 comparable companies in Greater London (median £16k, upper quartile £276k).
02
Ownership and control
- Mantix Consulting Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Nias Holdings Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Castle Sharif Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 November 20214 yrs ago
- Next accounts due
- 30 August 202654 days overdue
- Confirmation statement due
- 24 November 2026in 32 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£12k
−59%vs Nov 2023Not reported
2
+100%vs Nov 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2024 | −£5,272 | £12k | £106k | £213k | — | — | 2 |
| 30 November 2023 | £511 | £29k | £105k | £235k | — | — | 1 |
Current ratio0.66Current assets ÷ creditors within one year
Cash per employee£5,912Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-5,272 at 30 November 2024
- Net assets down 25% or more on the prior period-1131.7% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.66
- Incorporated two to five years agoIncorporated 10 November 2021
- Accounts past their due dateDue 30 August 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 32 days
- Next accounts due54 days overdue
- Accounts period endNet liabilities £5,272 · small accounts
- Accounts period endNet assets £511 · small accounts
- Incorporated
08
Similar companies in Greater London
09
Reminders for JERICHO PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.